The integration of AI into digital pathology has the potential to transform cancer diagnostics by enabling scalable, ...
The AI in cancer diagnostics market presents significant opportunities driven by advancements in AI and machine learning ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, it is becoming increasingly difficult to keep track and to select the ...
A new study in Science Bulletin presents DVSTP, a deep learning system that integrates pathology images with spatial ...
Man’s best friend may become cancer’s worst enemy.
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Clinicogenomic Real-World Data Enable Prediction of Hospital Readmissions at a Comprehensive Cancer Center Publicly available WSI of pancreatic ductal adenocarcinoma resections from three cohorts were ...
Pediatric oncology is rapidly advancing through precision therapeutics, biomarker-informed trials, and adaptive treatment strategies designed to improve ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results